Related Experiment Video
Updated: Jun 30, 2026

3D-Neuronavigation In Vivo Through a Patient's Brain During a Spontaneous Migraine Headache
Published on: June 2, 2014
Melatonin to prevent migraine or tension-type headache in children
Silvia Miano1, Pasquale Parisi, Andrea Pelliccia
1Child Neurology, Paediatric Sleep Centre and Paediatric Headache Centre, La Sapienza University - II Faculty c/o Sant' Andrea Hospital, Rome, Italy.
Insights
Melatonin prophylaxis significantly reduced headache frequency in children. Over half of participants experienced a greater than 50% decrease in headache attacks, with some reporting complete remission.
Area of Science:
- Pediatric Neurology
- Pharmacology
Background:
- Primary headache disorders are common in children.
- Preventive treatments for pediatric headaches are needed.
Purpose of the Study:
- To evaluate the efficacy of melatonin as a prophylactic treatment for primary headaches in children.
- To assess the impact of melatonin on headache frequency and severity.
Main Methods:
- An open-label trial involving 22 children (ages 6-16) with primary headaches.
- A one-month baseline period followed by 3 months of oral melatonin (3 mg nightly).
- Participants included children with recurrent migraine (with or without aura) and chronic tension-type headache.
Main Results:
- 14 out of 21 subjects reported a >50% reduction in headache attacks compared to baseline.
- 4 subjects reported no headache attacks after melatonin treatment.
- One subject discontinued due to excessive daytime sleepiness.
Conclusions:
- Melatonin shows promising results for preventing primary headaches in children.
- Further randomized placebo-controlled trials are warranted to confirm melatonin's effectiveness.
- Melatonin may be a viable option for pediatric headache prophylaxis.
Abstract:
We designed a 3-month open label trial of melatonin prophylaxis in children with primary headache. After a one month baseline period without receiving preventive drugs, all children received a 3-month course of melatonin, 3 mg, administered orally, at bedtime. A total of 22 children were enrolled (10 boys, mean age 12.2+/-2.6 years, age range 6-16 years), 13 had recurrent migraine without aura, 1 with aura and 8 had chronic tension-type headache. When the trial ended, 14 of the 21 subjects reported that the headache attacks had decreased by more than 50% in respect to baseline and 4 of them reported having no headache attacks. After receiving melatonin for one month one subject dropped out because of excessive daytime sleepiness. Our promising results warrant randomized placebo-controlled trials in children to assess the real effectiveness of melatonin in preventing primary headache.
Related Concept Videos
Nightmares and Night Terrors
Nightmares often...
Management of Insomnia
Sedatives and Hypnotics Drugs: Miscellaneous Agents
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Sedatives and Hypnotics: Overview
Sedative-hypnotics are categorized into barbiturates, benzodiazepines (BZDs), and non-benzodiazepines or Z-drugs. These drugs work by suppressing central nervous system activity, and this suppression is dose-dependent. Older sedative medications, like barbiturates, follow a linear curve in...
Equilibrium and Balance
Insomnia
Multiple factors contribute...

